Form 4: Arteris CEO Charles Janac Discloses Recent Stock Sales Under Pre-Arranged Plan

Arteris, Inc. President and CEO Charles K. Janac reported the sale of 18,968 shares of common stock in early July, primarily to cover tax liabilities and under a pre-arranged trading plan.

Summary

• Charles K. Janac, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported sales of common stock.
• On July 2, 2025, Janac sold a total of 7,153 shares of common stock at a price of $8.9924 per share.
• These sales on July 2, 2025, were conducted to satisfy the reporting person's tax liability arising from the release of restricted stock units.
• On July 3, 2025, an additional 11,815 shares of common stock were sold at a weighted average price of $9.2451 per share.
• The sales on July 3, 2025, were executed pursuant to a Rule 10b5-1 trading plan adopted by Janac on March 5, 2025.
• The price for the July 3rd sales ranged from $9.12 to $9.40 per share.
• Following these transactions, Janac directly beneficially owns 284,030 shares of common stock.
• Indirect beneficial ownership includes 9,889,071 shares held by Bayview Legacy, LLC, where Janac is the manager, and 56,252 shares held by Charles and Lydia Janac Trust, where Janac serves as trustee.

Sentiment

Score: 6

Explanation: The insider sales by the CEO were primarily for tax obligations related to restricted stock units and under a pre-arranged 10b5-1 trading plan, which are common and generally expected reasons for such transactions. The CEO retains substantial indirect beneficial ownership, indicating continued alignment with shareholder interests.

Positives

• The sales were partly for tax liabilities, which is a common and expected reason for insider sales.
• A significant portion of the sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a structured approach to stock disposition rather than opportunistic selling.
• Charles K. Janac retains substantial indirect beneficial ownership of 9,889,071 shares through Bayview Legacy, LLC, and 56,252 shares through Charles and Lydia Janac Trust, in addition to 284,030 directly held shares, demonstrating continued alignment with shareholder interests.

Negatives

• The transactions represent a reduction in direct beneficial ownership by a key executive and 10% owner.

Risks

• While sales were for tax liabilities and under a 10b5-1 plan, a pattern of ongoing insider selling could be interpreted negatively by the market, potentially impacting investor sentiment.
• The disclosure of sales, even for legitimate reasons, could lead to questions about management's long-term view of the company's stock performance if not clearly understood by investors.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Charles K. Janac is deemed to have voting and dispositive power over 9,889,071 shares beneficially owned by Bayview Legacy, LLC, where he is the manager.
• Charles K. Janac serves as trustee for the Charles and Lydia Janac Trust, which holds 56,252 shares.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive could be perceived as a slight negative, but the reasons (tax liability, 10b5-1 plan) mitigate concerns. The executive retains significant ownership, maintaining alignment.

Key Dates

Keywords

Arteris Inc, AIP, Form 4, Insider Trading, Stock Sales, Charles K. Janac, CEO, President, Director, 10b5-1 Plan, Restricted Stock Units, Tax Liability, Beneficial Ownership